2011
DOI: 10.2174/138161211798194512
|View full text |Cite
|
Sign up to set email alerts
|

A Prodrug Approach to Improve the Physico-Chemical Properties and Decrease the Genotoxicity of Nitro Compounds

Abstract: In therapeutics research, the nitro compounds are part of an important group of drugs with multiple pharmacological activities. However, in drug design, the inclusion of a nitro group in a molecule changes the physico-chemical and electronic properties and is associated with increased mutagenicity and carcinogenicity. In addition, several studies have related the relationship between the antimicrobial and/or anti-protozoal activity and the mutagenic effect to reduction of the nitro group. This work reviews the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 51 publications
(24 citation statements)
references
References 46 publications
(92 reference statements)
1
23
0
Order By: Relevance
“…Moreover, metronidazole therapy can occasionally cause more severe side effects such as pancreatitis, neutropenia, neuropathies, or CNS toxicities 12. These adverse effects could be attenuated with better control over the pharmacokinetics of metronidazole 13. Hence, in this proof‐of‐concept study, we elected to attach metronidazole to ribonucleoside 3′‐phosphates to assess the attributes of this pro‐moiety for orally available drugs (Figure 1).…”
Section: Methodsmentioning
confidence: 99%
“…Moreover, metronidazole therapy can occasionally cause more severe side effects such as pancreatitis, neutropenia, neuropathies, or CNS toxicities 12. These adverse effects could be attenuated with better control over the pharmacokinetics of metronidazole 13. Hence, in this proof‐of‐concept study, we elected to attach metronidazole to ribonucleoside 3′‐phosphates to assess the attributes of this pro‐moiety for orally available drugs (Figure 1).…”
Section: Methodsmentioning
confidence: 99%
“…tamoxifen, shown as the nucleotide derivative 14 ). In the case of metronidazole, addition of the phosphate enhances water solubility 50-fold and the prodrug is cleaved rapidly in human serum [25]. Further derivatization of metronidazole through conjugation with a nucleoside 3′-phosphate has been explored as a strategy to enhance oral bioavailability [26].…”
Section: General Considerationsmentioning
confidence: 99%
“…The goals of prodrug design include but are not limited to the improvement of physicochemical properties [9,10], enhancement of biopharmaceutical profile [10,11], reduction of side effects [9,11], obtaining additive or synergistic effects [6,12], targeted delivery [11,13] or optimization for the route of administration [7,14,15]. …”
Section: Introductionmentioning
confidence: 99%